Skip to content
Screener

Beta Bionics BBNX Q2 2025 earnings

Reported July 29, 2025 · After market close

Revenue$23.2MBeat by $1.3M
EPS-$0.39Beat by $0.12
Revenue estimate$21.9M
EPS estimate-$0.51

Next report

Oct 27, 2026 (in 2 months)
Revenue estimate$35.0M
EPS estimate-$0.55

Financials

Q2 2025

Income statement

See full
Revenue$23.2M+54.4%
Gross profit$12.5M+54.7%
Operating income-$19.9M-68.6%
Net income-$16.9M-16.6%
EPS (diluted)-$0.39+83.5%

Balance sheet

See full
Cash & equivalents$35.1M+169%
Total debt$6.7M—
Total equity$301.6M+236%
Total assets$330.0M—

Cash flow

See full
Operating cash flow-$13.6M-11.1%
CapEx$1.8M+251%
Free cash flow-$15.4M-20.6%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$681.56M—
Enterprise value$653.17M—
P/S8.7×—

Profitability

See full
Gross margin53.9%-0.3pp
Operating margin-80.1%-18.7pp
Net margin-94%-24.2pp
FCF margin-79.5%-20.7pp

Returns & leverage

See full
Debt / equity0×—
Current ratio14.7×—

Segments

By product

See full
I Let$13.4M+14.7%
Single Use Products$5.2M+102%

By geography

See full
Non Us-—

FAQ

When did Beta Bionics report Q2 2025 earnings?
Beta Bionics (BBNX) reported Q2 2025 earnings on July 29, 2025 after market close.
What were Beta Bionics's Q2 2025 revenue and EPS?
Beta Bionics reported revenue of $23.2M and eps of $-0.39 for Q2 2025.
Did Beta Bionics beat estimates in Q2 2025?
Revenue beat the consensus estimate of $21.9M by $1.3M. EPS beat the consensus estimate of $-0.51 by $0.12.
Where can I find Beta Bionics's Q2 2025 SEC filings?
You can read the 8-K earnings release (0001171843-25-004780) and the 10-Q periodic report (0000950170-25-099652) directly on SEC EDGAR. The filing index links above go to sec.gov.